Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease.

Abstract

To determine how survival and clinical status were related to left ventricular (LV) size and systolic function after mitral valve replacement, 104 patients (48 mitral regurgitation [MR], 33 mitral stenosis [MS], and 23 MS/MR) with isolated mitral valve replacement were evaluated before and after surgery. Preoperative hemodynamic abnormalities by cardiac catheterization were improved 6 months after surgery in all three patient groups. The patients with MR exhibited reductions in LV end-diastolic volume index (EDVI) (117 +/- 51 to 89 +/- 27 ml/m2, p less than 0.001) and ejection fraction (EF) (0.56 +/- 0.15 to 0.45 +/- 0.13, p less than 0.001); however, the ratio of forward stroke volume to end-diastolic volume increased (0.32 +/- 0.21 to 0.45 +/- 0.17, p less than 0.001) because of the elimination of regurgitant volume. Survival analysis revealed that mortality was significantly higher in MS or MS/MR patients with postoperative EDVI more than 101 ml/m2 (p less than 0.001 and p less than 0.042, respectively) and in MR patients with postoperative EF less than or equal to 0.50 (p less than 0.031). Also, the majority of patients with MR or MS/MR and postoperative EDVI more than 101 ml/m2 and EF less than or equal to 0.50 were in New York Heart Association class III or IV. Multivariate logistic regression analysis in the patients with MR revealed that the strongest predictor of postoperative EF was preoperative EF (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial

“…10,11 We estimated that the incidence of cardiovascular events would be 40% lower in patients treated with valsartan than in those treated with amlodipine. Therefore, 1280 patients would be needed in each group (2560 in total), with a two-sided a-level of 0.05 and 90% power.…”

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

“…Findings consistent with pulmonary hypertension are worrisome because they indicate advanced disease with worsened prognosis. 544 An ECG and chest X-ray are useful in establishing rhythm and for assessment of the pulmonary vascularity and pulmonary congestion. imation of the severity of regurgitation.…”

Long-Term Prognosis of Isolated Significant Tricuspid Regurgitation

“…RV dysfunction may be a sign for optimal surgical timing in isolated TR patients, as in asymptomatic patients with severe mitral regurgitation and left ventricular dysfunction. [18][19][20] The actual mortality rate of patients with significant isolated TR who did not undergo TV surgery was 26% in 5 years, and it was higher especially in patients with more severe TR, pulmonary hypertension and RV systolic dysfunction. Long-standing significant TR causes hepatic failure, protein-losing enteropathy, lymphocytopenia, immunologic deficiency and renal dysfunction, 21,22 which may be responsible for the high mortality in patients with isolated significant TR.…”